{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-083019","form_type":"8-K","ticker":"HOOK","cik":"0001760542","company_name":"HOOKIPA Pharma Inc.","filed_at":"2024-07-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.437979+00:00","generated_at":"2026-05-31T15:58:57.531770+00:00","sec_items":["5.02","7.01","1.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"HOOKIPA Pharma appoints Dr. Malte Peters CEO and Terry Coelho CFO; launches strategic review for HB-200","bullets":["Dr. Malte Peters appointed CEO & President effective July 22, 2024; salary $630k, RSU award $700k.","Terry Coelho appointed EVP & CFO effective July 22, 2024; salary $480k, signing bonus $240k, RSU $450k.","Former CEO Jörn Aldag and CFO Reinhard Kandera separated July 22, resigned from board July 23.","Sean Cassidy appointed independent director and Audit Committee chair effective July 22.","Company launches strategic review to focus on HB-200 and create shareholder value; no impact on operations or trials."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-083019","json":"https://secwatch.observer/filing/0001104659-24-083019.json","markdown":"https://secwatch.observer/filing/0001104659-24-083019.md","text":"https://secwatch.observer/filing/0001104659-24-083019.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1760542/000110465924083019/0001104659-24-083019-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1760542/000110465924083019/tm2420181d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T15:58:57.531770+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"42501d517e","claim":"Malte Peters was appointed as Chief Executive Officer and President at HOOKIPA Pharma Inc..","evidence_excerpt":"the Company’s board of directors (the “Board”) appointed Malte Peters, M.D., as the Company’s Chief Executive Officer and President, effective July 22, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1760542/000110465924083019/0001104659-24-083019-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer and President"}],"fact_type":"executive_change"},{"claim_id":"4f4e8f4513","claim":"Reinhard Kandera departed as Chief Financial Officer at HOOKIPA Pharma Inc..","evidence_excerpt":"On July 22, 2024, Reinhard Kandera separated as the Chief Financial Officer of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1760542/000110465924083019/0001104659-24-083019-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"separated"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"5b92f3f04d","claim":"Reinhard Kandera resigned as Director at HOOKIPA Pharma Inc..","evidence_excerpt":"Mr. Kandera also resigned from his position as a director of the Company on July 23, 2024 following his separation as Chief Financial Officer","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1760542/000110465924083019/0001104659-24-083019-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"6e308d7dce","claim":"Joern Aldag departed as Chief Executive Officer at HOOKIPA Pharma Inc..","evidence_excerpt":"On July 22, 2024, Joern Aldag separated as the Chief Executive Officer of HOOKIPA Pharma Inc. (the “Company”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1760542/000110465924083019/0001104659-24-083019-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"separated"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"723322b78a","claim":"Joern Aldag resigned as Director at HOOKIPA Pharma Inc..","evidence_excerpt":"Mr. Aldag also resigned from his position as a director of the Company on July 23, 2024 following his separation as Chief Executive Officer","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1760542/000110465924083019/0001104659-24-083019-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}